Brian G. Drazba
2020 - MEI Pharma
In 2020, Brian G. Drazba earned a total compensation of $981.8K as Chief Financial Officer at MEI Pharma, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $80,400 |
|---|---|
| Non-Equity Incentive Plan | $120,600 |
| Option Awards | $378,836 |
| Salary | $402,000 |
| Total | $981,836 |
Drazba received $402K in salary, accounting for 41% of the total pay in 2020.
Drazba also received $80.4K in bonus, $120.6K in non-equity incentive plan and $378.8K in option awards.
Rankings
In 2020, Brian G. Drazba's compensation ranked 8,722nd out of 13,090 executives tracked by ExecPay. In other words, Drazba earned more than 33.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,722 out of 13,090 | 33rd |
Division Manufacturing | 3,717 out of 5,620 | 34th |
Major group Chemicals And Allied Products | 1,503 out of 2,253 | 33rd |
Industry group Drugs | 1,309 out of 1,953 | 33rd |
Industry Pharmaceutical Preparations | 968 out of 1,458 | 34th |
Source: SEC filing on October 27, 2020.
Drazba's colleagues
We found three more compensation records of executives who worked with Brian G. Drazba at MEI Pharma in 2020.